The impact of low advanced glycation end products diet on obesity and related hormones: a systematic review and meta-analysis.
Study Goal
The researchers aimed to assess the effect of a low advanced glycation end products (AGE) diet on obesity and related hormones in adults.
Results Summary
The meta-analysis of 13 studies showed a significant decrease in BMI (weighted mean difference: -0.3 kg/m²) with a low AGE diet, though results across trials were conflicting.
Population
Adults
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
dietary advanced glycation end products (AGE) | neutral | obesity factors and related hormones | adults | - | investigated the effect | #1 |
low advanced glycation end products diet | neutral | obesity and related hormones | - | - | assess the effect | #2 |
low advanced glycation end products diet | decrease | BMI | - | -0.3 kg/m² | significant decrease | #3 |
Several randomized clinical trials (RCTs) have investigated the effect of dietary advanced glycation end products (AGE) on obesity factors and related hormones in adults; results were conflicting. Therefore, a study was performed to assess the effect of low advanced glycation end products diet on obesity and related hormones. A comprehensive literature search without any limitation on language was conducted using the following bibliographical databases: Web of Science, Scopus, Ovid MEDLINE, Cochrane, and Embase up to October, 2019. From the eligible trials, 13 articles were selected for the systematic review and meta-analysis. Our systematic reviews and meta-analyses have shown a significant decrease in BMI (WMD: - 0.3 kg/m